Literature DB >> 17240219

Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature.

Norbert Gleicher1.   

Abstract

Preeclampsia-eclampsia (PE-E) is a poorly understood condition of human pregnancy, which can affect multiple organs and is a leading cause of maternal deaths worldwide. The etiology and pathophysiology remain enigmas, however, which hampers progress in prevention, diagnosis, and treatment of this condition. PE-E is characterized by many features typically seen in autoimmune diseases, or in association with autoimmune reactions. Although this does not mean that PE-E should be considered an autoimmune condition, it does suggest that abnormal autoimmune processes play an important part in the clinical presentation of PE-E. In that regard, PE-E mimics autoimmune responses also observed in situations of allograft rejection and graft-versus-host disease (GVHD). Indeed, PE-E shares many other clinical and laboratory characteristics with allograft rejection and GVHD. Recognizing PE-E as a clinical condition that is characterized by autoimmune abnormalities may facilitate earlier and more specific diagnosis, along with preventive and more specific therapies for women at risk.

Entities:  

Mesh:

Year:  2007        PMID: 17240219     DOI: 10.1016/j.ajog.2006.09.016

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  The impact of fetal gender on prematurity in dichorionic twin gestations after in vitro fertilization.

Authors:  Andrea Weghofer; Katharina Klein; Maria Stammler-Safar; Christof Worda; David H Barad; Peter Husslein; Norbert Gleicher
Journal:  Reprod Biol Endocrinol       Date:  2010-06-10       Impact factor: 5.211

Review 2.  Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases.

Authors:  Norbert Gleicher
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

3.  Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia.

Authors:  C Liu; N Zhang; H Yu; Y Chen; Y Liang; H Deng; Z Zhang
Journal:  Placenta       Date:  2010-12-08       Impact factor: 3.481

Review 4.  Angiotensin receptors, autoimmunity, and preeclampsia.

Authors:  Yang Xia; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

5.  Prenatal and perinatal factors and risk of multiple sclerosis.

Authors:  Hannah Gardener; Kassandra L Munger; Tanuja Chitnis; Karin B Michels; Donna Spiegelman; Alberto Ascherio
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

Review 6.  Decidual Natural Killer Cells: A Good Nanny at the Maternal-Fetal Interface During Early Pregnancy.

Authors:  Yuefang Liu; Shujun Gao; Yangjing Zhao; Hui Wang; Qiong Pan; Qixiang Shao
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

7.  Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia.

Authors:  Katherine Leavey; Shannon A Bainbridge; Brian J Cox
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

8.  Epigenetic regulation of placental gene expression in transcriptional subtypes of preeclampsia.

Authors:  Katherine Leavey; Samantha L Wilson; Shannon A Bainbridge; Wendy P Robinson; Brian J Cox
Journal:  Clin Epigenetics       Date:  2018-03-02       Impact factor: 6.551

Review 9.  Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum.

Authors:  Sinuhe Hahn; Paul Hasler; Lenka Vokalova; Shane Vontelin van Breda; Nandor Gabor Than; Irene Mathilde Hoesli; Olav Lapaire; Simona W Rossi
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

10.  Placental gene-expression profiles of intrahepatic cholestasis of pregnancy reveal involvement of multiple molecular pathways in blood vessel formation and inflammation.

Authors:  QiaoLing Du; YouDong Pan; YouHua Zhang; HaiLong Zhang; YaJuan Zheng; Ling Lu; JunLei Wang; Tao Duan; JianFeng Chen
Journal:  BMC Med Genomics       Date:  2014-07-07       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.